Status:
UNKNOWN
Rapid Cortisol Assay in Adrenal Vein Sampling
Lead Sponsor:
University Hospital Padova
Conditions:
Primary Aldosteronism Due to Aldosterone Producing Adenoma
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Background: Adrenal vein sampling (AVS) is the gold standard test for the subtyping of primary aldosteronism (PA). This procedure is hampered by unsuccessful bilateral cannulation of adrenal veins, wh...
Detailed Description
Primary aldosteronism (PA) is a common form of hypertension caused by excess aldosterone secretion: it involves over 11% of the patients referred to specialized hypertension centres \[1\], about one f...
Eligibility Criteria
Inclusion
- According to current guidelines consecutive patients with biochemical diagnosis of PA, who seek surgical cure of PA will be recruited for this study.These patients have a compelling indication to AVS before being referred or not for adrenalectomy.
- \-
Exclusion
- i) refusal of the center's to participate in the study; ii)refusal of the patientto undergo AVS and/or contraindications to the general anesthesia that is required for laparoscopic adrenalectomy; iii) cortisol -and aldosterone co-secreting adenoma.
- \-
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03449797
Start Date
April 1 2018
End Date
July 31 2020
Last Update
March 9 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.